genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2014
arGEN-X
News
arGEN-X Partners with LLS on Development of Waldenström’s Macroglobulinemia Treatment
Drug Discovery
ArGEN-X Obtains €1.3M to Advance Antibody Platform
Drug Discovery
arGEN-X Raises $37M to Progress mAb Pipeline
Cancer
ArGEN-X Licenses BioWa’s Potelligent Platform to Generate More Potent Antibodies
Drug Discovery
Lilly to Use ArGEN-X Technology for mAb R&D
Cancer
ArGEN-X Wins €1.5M IWT Grant to Progress Camelid-Derived Human Antibody Pipeline
News
ArGEN-X Brings Total Series A Financing up to $14.3M
News
arGEN-X Opens R&D Center in Flanders for Camelid-Derived Antibodies
Scroll Up
Scroll Up
